SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-210772
Filing Date
2023-08-11
Accepted
2023-08-11 16:18:55
Documents
2
Group Members
EMILY FAIRBAIRN

Document Format Files

Seq Description Document Type Size
1 SC 13G d514664dsc13g.htm SC 13G 59802
2 EX-99.1 d514664dex991.htm EX-99.1 5029
  Complete submission text file 0001193125-23-210772.txt   66613
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Subject) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92777 | Film No.: 231164405
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10 ORINDA VIEW ROAD ORINDA CA 94563
Business Address 10 ORINDA VIEW ROAD ORINDA CA 94563 (646) 600-6438
Transcend Partners Opportunity Fund I LLC (Filed by) CIK: 0001832019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G